ArticleJournal for immunotherapy of cancer2025

Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma.

Chunxiang Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.